SurModics to Present at Morgan Keegan Equity Conference
Presentation will be Webcast live Thursday, September 9 at 10:40 a.m. CDT
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Sept. 8, 2004--SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery solutions to medical device manufacturers, announced today that it will make a presentation to the investment community at the Morgan Keegan Equity Conference.
Phil Ankeny, Vice President, Business Development and Chief Financial Officer, is scheduled to present an overview of the Company and its growth strategies on Thursday, September 9, at 10:40 a.m. (CDT). The conference runs from September 8-10 at the JW Marriott in New Orleans. Over 100 growth companies are expected to present.
A link to a Webcast of the presentation will be available in the investor relations section of SurModics' Web site at www.surmodics.com. The Webcast link will remain archived on the Company's site until Friday, October 8.
SurModics, Inc., a leading provider of surface modification and drug delivery solutions, licenses its proprietary technologies to medical device, diagnostics, and biotechnology companies around the world. A significant portion of SurModics' revenue is generated through royalties on the sale of coated products. SurModics' Internet address is www.surmodics.com.
CONTACT: SurModics, Inc., Eden Prairie
Phil Ankeny, 952-829-2700
SOURCE: SurModics, Inc.